NO20060109L - Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning - Google Patents

Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning

Info

Publication number
NO20060109L
NO20060109L NO20060109A NO20060109A NO20060109L NO 20060109 L NO20060109 L NO 20060109L NO 20060109 A NO20060109 A NO 20060109A NO 20060109 A NO20060109 A NO 20060109A NO 20060109 L NO20060109 L NO 20060109L
Authority
NO
Norway
Prior art keywords
alat
alpha
preparation
detergents
antitrypsin solution
Prior art date
Application number
NO20060109A
Other languages
English (en)
Norwegian (no)
Inventor
Juergen Romisch
Petra Schulz
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20060109L publication Critical patent/NO20060109L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
NO20060109A 2003-08-12 2006-01-06 Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning NO20060109L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
NO20060109L true NO20060109L (no) 2006-02-15

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060109A NO20060109L (no) 2003-08-12 2006-01-06 Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning

Country Status (22)

Country Link
US (1) US20060194300A1 (pl)
EP (1) EP1654284B1 (pl)
JP (1) JP4668904B2 (pl)
KR (1) KR20060070543A (pl)
CN (1) CN1867582B (pl)
AT (1) ATE428730T1 (pl)
AU (1) AU2004262578B2 (pl)
BR (1) BRPI0412835A (pl)
CA (1) CA2534900A1 (pl)
DE (1) DE602004020632D1 (pl)
DK (1) DK1654284T3 (pl)
ES (1) ES2324168T3 (pl)
IL (1) IL172868A0 (pl)
NO (1) NO20060109L (pl)
PL (1) PL1654284T3 (pl)
PT (1) PT1654284E (pl)
RS (1) RS20060077A (pl)
RU (1) RU2370500C2 (pl)
SI (1) SI1654284T1 (pl)
UA (1) UA86775C2 (pl)
WO (1) WO2005014648A1 (pl)
ZA (1) ZA200601206B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE391730T1 (de) * 2003-09-22 2008-04-15 Kamada Ltd Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
CN100562523C (zh) * 2006-07-26 2009-11-25 河北大安制药有限公司 α1-抗胰蛋白酶的制备方法
NZ584766A (en) * 2007-11-02 2012-12-21 Grifols Therapeutics Inc Method, composition, and article of manufacture for providing alpha-1 antitrypsin
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) * 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
MX381279B (es) 2015-06-26 2025-03-12 Ferring Bv Métodos de purificación y/o inactivación viral.
JP6946313B2 (ja) * 2016-02-03 2021-10-06 プラズマ テクノロジーズ エルエルシーＰｌａｓｍａ Ｔｅｃｈｎｏｌｏｇｉｅｓ， Ｌｌｃ 血液系物質からタンパク質を抽出する方法
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
DE3877041T2 (de) * 1987-04-27 1993-04-22 Miles Inc Verfahren zur herstellung von hochgereinigtem alpha-1-proteinase-inhibitor.
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
EP0871671A1 (en) * 1995-09-07 1998-10-21 PPL Therapeutics (Scotland) Limited Purification of alpha-1 proteinase inhibitor
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α２プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
RU2370500C2 (ru) 2009-10-20
EP1654284A1 (en) 2006-05-10
DK1654284T3 (da) 2009-07-20
RS20060077A (sr) 2008-08-07
PL1654284T3 (pl) 2009-09-30
UA86775C2 (ru) 2009-05-25
IL172868A0 (en) 2006-06-11
CA2534900A1 (en) 2005-02-17
SI1654284T1 (sl) 2009-10-31
ZA200601206B (en) 2007-05-30
WO2005014648A1 (en) 2005-02-17
EP1654284B1 (en) 2009-04-15
JP4668904B2 (ja) 2011-04-13
ES2324168T3 (es) 2009-07-31
US20060194300A1 (en) 2006-08-31
AU2004262578B2 (en) 2010-05-06
RU2006107533A (ru) 2006-07-27
CN1867582B (zh) 2010-06-16
ATE428730T1 (de) 2009-05-15
BRPI0412835A (pt) 2006-09-26
KR20060070543A (ko) 2006-06-23
AU2004262578A1 (en) 2005-02-17
DE602004020632D1 (de) 2009-05-28
JP2007523883A (ja) 2007-08-23
PT1654284E (pt) 2009-07-06
CN1867582A (zh) 2006-11-22

Similar Documents

Publication Publication Date Title
Zwahlen et al. Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosis
Parker et al. Action and timing of BacC and BacD in the late stages of biosynthesis of the dipeptide antibiotic bacilysin
PL1654284T3 (pl) Sposób uzyskiwania roztworu alfa-1-antytrypsyny
UA107174C2 (uk) Кристалічні форми саксагліптину та процес їх одержання (варіанти)
ECSP077317A (es) Procedimiento para producir derivados de amina opticamente activos
NO20052071L (no) Bezofuranforbindelser, preparater og metoder for behandling og forebygging av hepatitt C virale infeksjoner og relaterte sykdommer.
NO20073880L (no) Fremgangsmåte for fremstilling av salt
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
NO20045070L (no) Fremgangsmate for a frembringe en 2-18F-fluor-2-deoksy-D-glukose(18F-FDG)-losning
Azúa et al. Release and consumption of D-amino acids during growth of marine prokaryotes
NO20081681L (no) N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
ATE270667T1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
YU45793B (sh) Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže
Aman et al. From adenosine to 3 ‘-deoxyadenosine: development and scale up
CN106256830B (zh) 一种氘代的ido抑制剂及其制备方法和用途
NZ510748A (en) Crystal of diuridine tetraphosphate or salt thereof
Grossi et al. Decomposition of S-nitrosothiols: Unimolecular versus autocatalytic mechanism
FR2866890B1 (fr) Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
IT1311984B1 (it) Procedimento per la preparzione di gabapentin.
BRPI0416274A (pt) método para produzir solução de amÈnio de ácido orgánico
IT1301993B1 (it) Processo per la preparazione di zofenopril sale di calcio.
DK1280812T3 (da) Cyclipostiner, fremgangsmåde til deres fremstilling og anvendelse af samme
DE602004032024D1 (de) Behandlung hochleistungsfähiger pigmentfarbstoffe mit dispergierenden etheramin-salzen
AR002510A1 (es) Un procedimiento para la preparacion de derivados de 1-(3-trialquilsilil- fenil)-2,2,2-trifluorometiletanona que son utiles en el tratamiento de laenfermedad de alzheimer y demencia senil y procedimiento para la purificacion de dicho derivado con dicho procedimiento de preparacion.
Gallati et al. Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application